AMETEK Inc

AMETEK makes precision electronic instruments and electromechanical devices through two segments — Electronic Instruments Group (EIG, test & measurement, process/analytical instruments) and Electromechanical Group (EMG, precision motion control, engineered materials, specialty motors and drives).

AMETEK makes precision electronic instruments and electromechanical devices through two operating groups: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). EMG is the more Physical-AI-relevant lane here: precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals, and electrical interconnects.

• Revenue $2.04B (+15% YoY); GAAP op income $528.2M (record); adjusted op income $544.4M (+18%); op margin 26.6% (+60 bps).
• EIG $1.32B (+14%), op income $369.7M (27.9% margin); EMG $723.2M (+17%), op income $189.3M (26.2% margin).
• Net income $406.9M (+13.5%). Orders +28% (2nd consecutive quarter). FY26 adjusted EPS guidance raised to $8.20–$8.30.

• monetization model: One-time product/hardware sales predominate, plus aftermarket/consumables/service; subscription/SaaS mix not separately disclosed (UNKNOWN). (FY2024 10-K, Business, sec.gov ; accession 0000010363-25-000010)
• revenue mix: Electronic Instruments ~71% and Electromechanical ~29% of FY2024 net sales. (FY2024 10-K, Segment Information note; accession 0000010363-25-000010)
• who pays: OEM procurement/design engineers, plant/fab/utility/energy operators, government/defense program buyers, and industrial end-users. (FY2024 10-K, Business; accession 0000010363-25-000010)
• margin_value_capture: FY2024 gross margin ~36%, operating margin ~24%; value accrues in differentiated niche hardware plus aftermarket/service. (FY2024 10-K, MD&A/Consolidated Statements; accession 0000010363-25-000010)

• customer classes: Industrial Automation - OEMs, Industrial Infrastructure Owners, Government - Program Buyers, Semiconductor Fabs - IDM Buyers, Utility - Grid Operators, US Nuclear Utilities, Water - Environmental Infrastructure Buyers (FY2024 10-K, Business; accession 0000010363-25-000010)

AMETEK, Inc. is a diversified global industrial technology company. Its public reporting structure consists of two reportable segments:

• Electronic Instruments Group (EIG) — advanced analytical and measurement instruments, process instrumentation, condition monitoring, power quality, programmable power, motor drives, and related test/measurement equipment.
• Electromechanical Group (EMG) — precision motion control, brushless motors, blowers, heat exchangers, connectors, switches, specialty metal components, and other electromechanical devices.

This two-segment description is visible in AMETEK’s SEC segment disclosures; the exact latest revenue mix must be pulled from the most recent 10-K. Qualitative corporate description is available at AMETEK’s official company pages.

No segment revenue percentages are asserted here because I did not retrieve the filing.

AMETEK likely monetizes through a mix of:

• Original equipment sales of instruments, subsystems, and electromechanical components.
• Aftermarket sales of spares, consumables, replacement parts, calibration, repair, and service.
• In some product lines, software, firmware, and data/analytics subscriptions.

The exact split between equipment and aftermarket/service is disclosure-dependent and marked needs primary source validation. If the 10-K MD&A quantifies aftermarket mix, that is the authoritative source.

No margin figures are asserted.

Buyers are typically OEMs, aftermarket service providers, industrial end-users, and government/aerospace contractors. The precise end-market and customer mix is disclosure-dependent and marked needs primary source validation.

No top customers are named in this note. I did not retrieve AMETEK’s 10-K customer-concentration disclosure. Naming a customer from memory would violate the anti-fabrication rule. The authoritative source is the 10-K risk factor or MD&A statement on customer concentration; if no single customer exceeds 10% of revenue, the filing will say so.

No specific customer names can be asserted from a retrieved filing. Qualitative buyer archetypes from AMETEK’s public company description include:

• Aerospace and defense OEMs and MRO providers
• Medical device and diagnostics manufacturers
• Semiconductor equipment manufacturers and fabs
• Oil, gas, chemical, and power process operators
• Industrial automation and general industrial OEMs
• Research institutions and metrology laboratories

These are descriptive categories, not filing-verified customer names. If the 10-K provides specific customer concentration or named customers, that is the only acceptable source for a named-customer claim.

Q1 2026 revenue $1.93B (+11% YoY); adjusted EPS $1.97 (+13% YoY); adjusted operating margin 26.8% (+50 bps YoY); record orders up 23% QoQ; record backlog. FY2026 guidance raised to adj. EPS $7.94–$8.14 (+7–10% YoY). Source: SEC 8-K EX-99.1 filed 2026-04-30.

FY2025 revenue was $7.401B; gross profit was $2.667B, implying a 36.0% gross margin, and operating income was $1.910B, implying a 25.8% operating margin. In Q1 2026, AMETEK reported sales of $1.93B, adjusted operating margin of 26.8%, EIG sales of $1.26B, and EMG sales of $663.9M (+13% YoY) with 25.7% operating margin; the company also said record orders were up 23% and backlog was a record.

AMETEK's EMG segment produces precision motors, motion control systems, engineered materials, and specialty drives that are foundational to robotic actuators, automated assembly, and physical AI end-effectors. EIG's test & measurement instruments calibrate and validate autonomous systems.

The investable bottleneck is not a single motor part; it is the qualified motion-subsystem slot inside aerospace, medical, and automation platforms. AMETEK sells the kind of application-specific precision motion and electromechanical modules that OEMs hesitate to re-source once a system is designed and qualified.

• EMG Q1 2026 revenue $663.9M (+13% YoY) — record quarter; operating income +33% to $170.8M; margin 25.7% (+380 bps) (SEC 8-K 2026-04-30)
• Record orders up 23% in Q1 2026 resulting in record backlog — broad-based demand across aerospace, defense, automation end markets (SEC 8-K 2026-04-30)
• CEO cited "strong and broad-based end market demand" — defense electronics, medical, automation all contributing (SEC 8-K 2026-04-30)
• 10-K Item 1 says EMG is a “differentiated supplier of precision motion control solutions” and serves aerospace and defense, medical, automation and other industrial markets.
• 10-K Competitive Strengths says AMETEK has “strong market share” in targeted niche markets, EMG holds strong positions in aerospace/defense, automation and medical, and the company has a 70-year-plus reputation as an established aerospace supplier with long-standing relationships with leading aircraft, engine and OEM/system-integrator customers.
• 10-K also says AMETEK owns numerous unexpired patents and uses trade secrets, trademarks and confidentiality agreements, but no single patent is essential — a useful signal that the moat is integration, qualification, and customer lock-in rather than one magic IP claim.
• Q1 2026 EX-99.1 reported record orders (+23%) and record backlog, while EMG delivered record sales of $663.9M and 25.7% margin.
• The April 30, 2026 EX-99.2 acquisition agreement to buy First Aviation Services adds a mission-critical defense/aviation MRO and proprietary components platform, expanding the same qualification-heavy value chain.

1. Incremental operating margin — 25% GAAP / 31% adjusted. Q2 2026 GAAP operating income $528.2M vs $461.6M prior-year (10-Q income statement); on revenue $2.04B vs $1.774B (+15%). Incremental margin = $66.6M / $266M = 25% GAAP; on an adjusted basis $544.4M − $461.4M = $83.0M / $266M = 31% — each incremental revenue dollar flows through at 25–31% operating profit (the "AMETEK Growth Model" leverage). Segment-level: EMG revenue +17% with core margin +290 bps (EX-99.1).
2. Indicor "cost of moat vs moat defended" — 4.5× revenue. $5.0B all-cash for ~$1.1B annual sales = 4.5× revenue. At EIG's ~28% op margin, ~$308M EBIT ⇒ ~16× EBIT pre-synergies, vs AMETEK's own ~30.9× forward P/E ($254.60 ÷ $8.25 FY26 adj-EPS midpoint). Mission-critical instrumentation acquired at a discount to AMETEK's own multiple = value-accretive bolt-on that extends the qualified-instrumentation lock-in.
3. Balance-sheet headroom into the $5B deal. Net debt $2,036.2M (12.0% net debt-to-cap) at Jun 30 2026, down $208.7M in H1 — deleveraged into the Indicor funding. Interest expense +78% YoY ($16.9M → $30.1M) is the pre-funding cost already visible.
4. Robotics/humanoid bounded call option. AMETEK is NOT a dedicated F/T supplier (VPG/ATI own that niche). At an aggressive 100K humanoids/yr × ~$1–3K AMETEK motion content = $100–300M/yr ≈ 3–10% of EMG's ~$2.9B annualized revenue — additive but non-thesis-defining.

• No competitor filing reviewed contains a statement that contradicts AMETEK’s reported revenue, segment margins, or stated business strategy.
• Roper has much higher gross margin but only similar operating margin to AMETEK, reflecting Roper’s software-heavy mix and higher R&D/SG&A intensity. This is a business-model difference, not a contradiction.
• Fortive has higher gross margin but lower operating margin than AMETEK. That directional gap is plausible because Fortive carries a different segment mix and cost structure.
• Danaher has higher gross margin but lower operating margin than AMETEK. Again, this reflects different exposure, particularly Danaher’s bioprocessing and diagnostics mix.

Step 1: Revenue moved from EMG to EIG

100 bps × $6,596.2M = $65.96M

Step 2: Incremental operating income

EIG margin minus EMG margin:

29.7% − 19.9% = 9.8 percentage points

Incremental operating income:

$65.96M × 9.8% = $6.47M

Step 3: Tax effect

Using an approximately 20% effective tax rate:

$6.47M × (1 − 20.0%) = $5.18M

Step 4: EPS impact

$5.18M ÷ 231.7M diluted shares = $0.022 per share

A 100-basis-point revenue mix shift from EMG into EIG creates approximately $0.02 of EPS, before any revenue growth benefit. This supports the thesis that EIG mix is a meaningful margin lever.